An assessment of the antithymine and antipurine characteristics of MTA (LY231514) in CCRF-CEM cells.
Chen
V J
VJ
Division of Cancer Research, Lilly Research Laboratories, Indianapolis, IN 46285, USA.
Bewley
J R
JR
Smith
P G
PG
Andis
S L
SL
Schultz
R M
RM
Iversen
P W
PW
Tonkinson
J L
JL
Shih
C
C
D002460:Cell Line; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D005971:Glutamates / Q000494:pharmacology*; D006147:Guanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D000068437:Pemetrexed; D011687:Purines / Q000037:antagonists & inhibitors*; D013763:Tetrahydrofolates / Q000494:pharmacology; D013941:Thymine / Q000037:antagonists & inhibitors*
C105065:6R-2',5'-thienyl-5,10-dideazatetrahydrofolic acid; D005493:Folic Acid Antagonists; D005971:Glutamates; D011687:Purines; D013763:Tetrahydrofolates; D000068437:Pemetrexed; D006147:Guanine; D013941:Thymine; D008727:Methotrexate